News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News ZENITH: Novel Biologic Reduces Morbidity and Mortality in PAH L.A. McKeown November 26, 2024
News Conference News AHA 2024 Indian Patients Do Well on Dual-Combination Pills for Hypertension: TOPSPIN Caitlin E. Cox November 22, 2024
News Conference News AHA 2024 ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH Caitlin E. Cox November 18, 2024
News Conference News AHA 2024 Audits and Feedback Aid Pharmacist-Driven HF Care: PHARM-HF A&F Michael O'Riordan November 16, 2024
News Conference News AHA 2024 Rivaroxaban Doesn’t Cut Cognitive Decline, Stroke, or TIA in Younger AF Patients Shelley Wood November 16, 2024
News Daily News Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime Michael O'Riordan October 14, 2024
News Daily News Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows L.A. McKeown October 09, 2024
News Daily News Deprescribing Antihypertensives May Slow Cognitive Decline in Nursing Home Patients L.A. McKeown September 27, 2024
News Daily News CVD Risk Twofold Higher in Patients With Cancer: ASPREE Michael O'Riordan September 27, 2024
News Daily News Liraglutide Helps Shed Weight in Young Children With Obesity Todd Neale September 13, 2024
News Daily News Hypertension Control in the US Still Has a Long Way to Go Todd Neale September 12, 2024
News Conference News ESC 2024 SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients Michael O'Riordan September 02, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Conference News ESC 2024 Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events Caitlin E. Cox August 31, 2024
Presentation ESC 2024 BedMed and BedMed-Frail randomized controlled trials Presenter: Scott Garrison August 31, 2024
Presentation ESC 2024 QUADRO Phase III Study: Efficacy and Safety of the new Quadruple SPC Perindopril/Indapamide/Amlodipine/Bisoprolol in Patients with Resistant Hypertension Presenter: Stefano Taddei August 31, 2024